Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Phil Frohlich, Prescott Group Ask For PharmAthene Shareholder Meeting

PharmAthene, Prescott Group Capital Management: After Phil Frohlich, manager of Prescott Group Capital Management, disclosed his ownership of 10% of PharmAthene, Inc. (NYSEMKT:PIP) a couple weeks back, now he’s requested that the company call a special shareholder meeting for November 1. The scope of the meeting is adopting two resolutions in relation to PharmAthene’s civil actions against SIGA Technologies, and some general business matters.


The whole text of the letter sent by Frochlich to PharmAthene can be read through accessing the link below.

Prescott Group Capital Management Letter to PharmAthene

Earlier in May, the Delaware Supreme Court confirmed an earlier decision that SIGA Technologies broke its contractual obligation to negatiate in good faith. The case has been remanded to the Delaware Court of Chancery for reconsideration of the damages award, consistent with the Supreme Court’s opinion, PharmAthene said in a statement.

Benjamin J Taylor‘s  Sophrosyne Capital is also a shareholder of PharmAthene with a stake of 804,902 shares reported at the end of the second quarter.

Disclosure: none

Recommended Reading:

Icahn Gets Key Board Appointment at Enzon Pharmaceuticals

Lazard Asset Management Loves SJW Corp

Is This the End of Steven Cohen’s Insider Trading Battle?

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!